Tofacitinib N-Oxide Impurity 2 - Request Quote
Tofacitinib N-Oxide Impurity 2
| SZ CAT No: | SZ-T010127 |
| CAS No | NA |
| Mol.F. | C15H18N6O2 |
| Mol.Wt. | 314.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tofacitinib N-Oxide Impurity 2 is chemically 4-(((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine 3-oxide. Tofacitinib N-Oxide Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib N-Oxide Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Tofacitinib N-Oxide Impurity 2
Purchase Tofacitinib N-Oxide Impurity 2
Tofacitinib N-Oxide Impurity 2 suppliers
Tofacitinib N-Oxide Impurity 2 manufacturers
Tofacitinib N-Oxide Impurity 2 price
Order Tofacitinib N-Oxide Impurity 2
Enquire Tofacitinib N-Oxide Impurity 2
Tofacitinib N-Oxide Impurity 2 cost
Tofacitinib N-Oxide Impurity 2 Supplier
Tofacitinib N-Oxide Impurity 2 Distributor
Tofacitinib N-Oxide Impurity 2 for Method Validation
Tofacitinib Reference Standard
Tofacitinib N-Oxide Impurity 2 for ANDA Filing
Tofacitinib N-Oxide Impurity 2 for Forced Degradation Studies
Tofacitinib N-Oxide Impurity 2 Identification Standards
Tofacitinib N-Oxide Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.